Pharmacy Group Seeks to Block U.S. Drug Imports From Canada

Nov. 24, 2020, 12:29 AM

A pharmaceutical research group sued the Trump administration to block a policy aimed at lowering drug prices by allow some prescription medications to be imported -- and re-imported -- into the U.S. from Canada.

The policy announced in July poses “significant safety risks” because it would allow the imports without manufacturers’ “authorization or oversight,” according to the complaint by Pharmaceutical Research and Manufacturers of America filed Monday in Washington federal court.

Read More: Trump Poised to Lower Drug Payments to Match Foreign Prices

To contact the reporter on this story:
Robert Burnson in San Francisco at rburnson@bloomberg.net

To contact the ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.